Oculis Provides Updates at R&D Day on Late-Stage Clinical Tr

Completed enrollment in Phase 2b RELIEF trial of Licaminlimab , anti-TNF alpha eye drops in Dry Eye Disease ; topline results expected in Q2 2024Second Phase 3 trial of OCS-01 eye drops in Diabetic...

Related Keywords

Virginia , United States , Massachusetts , Eastern Virginia Medical School , Paris , France General , France , Vermont , Boston , Switzerland , American , Sylvia Cheung , Joanne Chang , Elizabeth Yeu , Corey Davis , Ramin Tadayoni , Arshadm Khanani , Macula Society , European Society Of Retina Specialists , Retina Research Foundation , Retina Society , Steering Committee , Nasdaq , Oculis Holding Ag Nasdaq , American Academy Of Ophthalmology Achievement Award , Reno School Of Medicine , Exchange Commission , American Society Of Retina Specialists , University Hospital , University Of Marseille , Clinical Research , Retina Department , Sierra Eye Associates , Rothschild Foundation Hospital , Simmons University , Paris Vision Institute , University Of Vermont , Parisv University , Oculis Holding , Globenewswire Inc , University Of Nevada , French Myopia Institute , Dry Eye Disease , Diabetic Macular Edema , Chief Scientific Officer , Scientific Advisory Board , Chief Human Resources Officer , Continental New York , Oculi Retina , Chief Executive Officer , Virginia Medical School , Eye Consultants , Scientific Advisory Teams , Scientific Advisory , Chief Human Resources , Retina Specialists , Department Chairman , Foundation Hospital , Principal Investigator , Paris Cit , Saint Louis , Ophthalmology Achievement Award , Gonin Award , Advisory Board , Eye Associates , Managing Partner , Clinical Associate Professor , Young Investigator Award , Chief People Officer , Senior Vice President , Axcella Therapeutics , Dry Eye , Diabetic Macular , Risk Factors ,